Published in J Mol Neurosci on November 07, 2010
Neuromuscular Magnetic Stimulation in ALS Patients (NMS-ALS) | NCT03618966
Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol (2013) 2.52
Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α. Neurobiol Dis (2012) 1.26
The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet (2012) 1.25
Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc Natl Acad Sci U S A (2013) 1.18
The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet (2013) 1.11
Spastic paraplegia mutation N256S in the neuronal microtubule motor KIF5A disrupts axonal transport in a Drosophila HSP model. PLoS Genet (2012) 1.05
Functional neuromuscular junctions formed by embryonic stem cell-derived motor neurons. PLoS One (2012) 0.98
Metformin treatment has no beneficial effect in a dose-response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. PLoS One (2011) 0.98
Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS One (2013) 0.97
Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J Neurosci (2014) 0.95
Fishing for causes and cures of motor neuron disorders. Dis Model Mech (2014) 0.90
Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav (2013) 0.90
Neurodegeneration in C. elegans models of ALS requires TIR-1/Sarm1 immune pathway activation in neurons. Nat Commun (2015) 0.90
Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis. J Neurosci Res (2013) 0.89
Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis. Neurol Res Int (2012) 0.88
Characterization of intercostal muscle pathology in canine degenerative myelopathy: a disease model for amyotrophic lateral sclerosis. J Neurosci Res (2013) 0.88
Neuromuscular effects of G93A-SOD1 expression in zebrafish. Mol Neurodegener (2012) 0.88
Retinoid receptors trigger neuritogenesis in retinal degenerations. FASEB J (2011) 0.86
Physiological characterization of human muscle acetylcholine receptors from ALS patients. Proc Natl Acad Sci U S A (2011) 0.85
Riluzole blocks human muscle acetylcholine receptors. J Physiol (2012) 0.84
A compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF functions. J Cell Sci (2015) 0.84
Safety of repeated transplantations of neurotrophic factors-secreting human mesenchymal stromal stem cells. Clin Transl Med (2014) 0.83
Ventilatory control in ALS. Respir Physiol Neurobiol (2013) 0.82
Neurodegeneration and microtubule dynamics: death by a thousand cuts. Front Cell Neurosci (2015) 0.82
CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol Med (2015) 0.81
Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice. J Comp Neurol (2014) 0.80
An in vitro assay to study induction of the regenerative state in sensory neurons. Exp Neurol (2014) 0.80
Delayed functional recovery in presymptomatic mSOD1(G93A) mice following facial nerve crush axotomy. J Neurodegener Regen (2013) 0.80
Dysfunctional mitochondrial Ca(2+) handling in mutant SOD1 mouse models of fALS: integration of findings from motor neuron somata and motor terminals. Front Cell Neurosci (2014) 0.80
Muscle ciliary neurotrophic factor receptor α promotes axonal regeneration and functional recovery following peripheral nerve lesion. J Comp Neurol (2013) 0.80
Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Neurol Res Int (2012) 0.80
Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis. Biomed Res Int (2016) 0.79
Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model. Front Cell Neurosci (2014) 0.79
Early gene expression changes in skeletal muscle from SOD1(G93A) amyotrophic lateral sclerosis animal model. Cell Mol Neurobiol (2014) 0.79
Matters of life and death: the role of chromatin remodeling proteins in retinal neuron survival. J Ocul Biol Dis Infor (2012) 0.79
Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS. Front Physiol (2016) 0.79
Golgi fragmentation in amyotrophic lateral sclerosis, an overview of possible triggers and consequences. Front Neurosci (2015) 0.78
Endomicroscopy and electromyography of neuromuscular junctions in situ. Ann Clin Transl Neurol (2014) 0.78
Measuring Neuromuscular Junction Functionality in the SOD1(G93A) Animal Model of Amyotrophic Lateral Sclerosis. Ann Biomed Eng (2015) 0.77
Dysregulated axonal RNA translation in amyotrophic lateral sclerosis. Wiley Interdiscip Rev RNA (2016) 0.77
Dietary Vitamin D3 Restriction Exacerbates Disease Pathophysiology in the Spinal Cord of the G93A Mouse Model of Amyotrophic Lateral Sclerosis. PLoS One (2015) 0.77
Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis. Invest Ophthalmol Vis Sci (2014) 0.77
Emerging Roles of Filopodia and Dendritic Spines in Motoneuron Plasticity during Development and Disease. Neural Plast (2015) 0.76
Muscle Expression of SOD1(G93A) Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice. Front Cell Neurosci (2015) 0.75
New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis. Transl Neurodegener (2015) 0.75
Glucose uptake heterogeneity of the leg muscles is similar between patients with multiple sclerosis and healthy controls during walking. Clin Biomech (Bristol, Avon) (2014) 0.75
Efr3a Insufficiency Attenuates the Degeneration of Spiral Ganglion Neurons after Hair Cell Loss. Front Mol Neurosci (2017) 0.75
A(a)LS: Ammonia-induced amyotrophic lateral sclerosis. F1000Res (2015) 0.75
Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis. Front Cell Neurosci (2015) 0.75
Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral Sclerosis. Front Neurol (2016) 0.75
Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates. J Comp Neurol (2015) 0.75
Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis. Skelet Muscle (2016) 0.75
Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase. Front Mol Neurosci (2016) 0.75
Human SOD1 ALS Mutations in a Drosophila Knock-In Model Cause Severe Phenotypes and Reveal Dosage-Sensitive Gain and Loss of Function Components. Genetics (2016) 0.75
Impaired neurodevelopment by the low complexity domain of CPEB4 reveals a convergent pathway with neurodegeneration. Sci Rep (2016) 0.75
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders. Front Neurosci (2017) 0.75
A double-blind, delayed-start trial of rasagiline in Parkinson's disease. N Engl J Med (2009) 5.81
VPS35 mutations in Parkinson disease. Am J Hum Genet (2011) 4.16
Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90
The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol (2004) 2.40
Validation of the freezing of gait questionnaire in patients with Parkinson's disease. Mov Disord (2009) 1.90
Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev (2002) 1.76
Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol (2003) 1.75
Handedness as a predictor of side of onset of Parkinson's disease. Parkinsonism Relat Disord (2008) 1.74
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. Lancet Neurol (2011) 1.68
Lesions outside the CNS in Parkinson's disease. Mov Disord (2009) 1.55
The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol (2006) 1.55
Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model. Exp Neurol (2006) 1.47
The hyperperfusion syndrome: an under-recognized complication of carotid endarterectomy. Isr Med Assoc J (2004) 1.40
Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase. J Mol Neurosci (2002) 1.25
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol (2007) 1.21
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries. Mov Disord (2006) 1.20
Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Invest Ophthalmol Vis Sci (2010) 1.18
Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev (2006) 1.17
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease. Mov Disord (2006) 1.14
Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin Biol Ther (2009) 1.13
DJ-1 protects against dopamine toxicity. J Neural Transm (Vienna) (2008) 1.11
Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Neurotoxicology (2008) 1.07
Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells (2009) 1.07
Apoptosis and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.06
Protective effects of neurotrophic factor-secreting cells in a 6-OHDA rat model of Parkinson disease. Stem Cells Dev (2009) 1.03
Induction of human mesenchymal stem cells into dopamine-producing cells with different differentiation protocols. Stem Cells Dev (2008) 1.01
Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol Med (2003) 1.00
A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J Neurochem (2004) 1.00
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis. Brain Res (2003) 0.98
Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice. Stem Cell Rev (2011) 0.98
Therapeutic potential of neurotrophic factors in neurodegenerative diseases. BioDrugs (2005) 0.97
Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J Mol Neurosci (2008) 0.97
Differentiated mesenchymal stem cells for sciatic nerve injury. Stem Cell Rev (2011) 0.96
Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury. PLoS One (2012) 0.96
Neurogenesis in the aged and neurodegenerative brain. Apoptosis (2010) 0.96
Antioxidant treatment in Alzheimer's disease: current state. J Mol Neurosci (2003) 0.96
Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy. J Biol Chem (2002) 0.96
Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Stem Cells Dev (2009) 0.95
DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS. J Mol Neurosci (2008) 0.94
123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med (2004) 0.93
Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. J Mol Neurosci (2009) 0.93
Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS. J Mol Neurosci (2012) 0.92
Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J Mol Neurosci (2004) 0.92
Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease. J Mol Neurosci (2009) 0.92
Trial designs used to study neuroprotective therapy in Parkinson's disease. Mov Disord (2012) 0.91
Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging. Stem Cells (2008) 0.91
Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis. Neurosci Res (2003) 0.90
A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease. Eur J Neurosci (2005) 0.89
Role of DJ-1 in Parkinson's disease. J Mol Neurosci (2006) 0.88
Docosahexaenoic acid and arachidonic acid are fundamental supplements for the induction of neuronal differentiation. J Lipid Res (2006) 0.88
Novel molecular imaging of cell death in experimental cerebral stroke. Brain Res (2007) 0.87
Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. Isr Med Assoc J (2009) 0.87
The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol (2007) 0.86
Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage. Neurosci Lett (2006) 0.86
Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression. Neurosci Lett (2007) 0.86
Hemin-induced apoptosis in PC12 and neuroblastoma cells: implications for local neuronal death associated with intracerebral hemorrhage. Neurotox Res (2003) 0.85
Unilateral lower limb rest tremor is not necessarily a presenting symptom of Parkinson's disease. Mov Disord (2010) 0.85
Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β-peptide. J Neurochem (2011) 0.85
Familial Parkinsonism with digenic parkin and PINK1 mutations. Mov Disord (2008) 0.85
Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state. Curr Pharm Des (2006) 0.84
Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains. Cytotherapy (2009) 0.84